Medical/Pharmaceuticals
Island Pharmaceuticals granted key patent for ISLA-101 in the United States
* Island's lead asset, ISLA-101 granted key patent from United Stated Patent & Trademark Office * Patent underpins Island's drug repurposing strategy to rapidly and efficiently develop antiviral therapies with a key focus being mosquito borne viral diseases, such as dengue fever. * Around 3...
2021-05-19 19:30
2407
111, Inc. Announces First Quarter 2021 Unaudited Financial Results
SHANGHAI, May 19, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the first quarte...
2021-05-19 14:17
5415
GeneQuantum Raises Hundreds of Millions RMB in Series C Funding
SUZHOU, China, May 18, 2021 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter "GeneQuantum") announced the completion of Series C fund raising of several hundreds of millions RMB. This series of fund raising is led by China Life Private Equity Investment, jointly by PICC Capi...
2021-05-19 10:30
1828
Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing
ST. CHARLES, Mo., May 18, 2021 /PRNewswire/ -- Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to ad...
2021-05-18 21:00
2039
Atonarp Announces $50M Series D Financing to Scale its Molecular Sensing and Digital Diagnostics Testing Platforms
Michael Marks, Founding Partner for WRVI Capital, Joins the Atonarp Board and Former Berkeley Lights CFO Shaun Holt Joins as Atonarp's Chief Operating Officer TOKYO, May 18, 2021 /PRNewswire/ -- Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, phar...
2021-05-18 18:00
3305
Nanoform's final clinical results confirm value proposition to the pharma industry
HELSINKI, Finland, May 18, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform "), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical study. The primary, secondary and optional exploratory objectives of the study were all met. Th...
2021-05-18 13:48
1456
U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, May 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX: 01801) and Eli Lilly and Company (NYSE: LLY) today jointly announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for sintilimab injection in...
2021-05-18 12:14
13101
Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern
* The publication is available as a pre-print on bioRxiv * Preclinical data demonstrates that a modified B.1.351 S-Trimer vaccine candidate induces broad neutralization against both the original SARS-CoV-2 strain and variants of concern (VoC) including the South African variant * A single bo...
2021-05-18 11:50
3130
Mycenax becomes Taiwan's first CDMO company to complete the CHO-S and CHOZN GS Cell Line Development with the Beacon(R) Optofluidic System
TAIPEI, May 18, 2021 /PRNewswire/ -- Mycenax (TWSE: 4726) becomes one of the first CDMO companies inAsia to adapt the Beacon Optofluidic system to cell line development services. Mycenax adopted Beacon® Optofluidic System, a high throughput selection system for single-cell cloning and quantifica...
2021-05-18 10:32
14290
Hummingbird Bioscience Raises US$125 Million in Series C Financing
* Investment round led by Novo Holdings, joined by a syndicate of international biotech investors * Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision therapeutics * Kenneth Harrison from Novo Ventures ...
2021-05-18 09:35
3036
Farrer Park Hospital Elevates Cancer Care with PIPAC Treatment for Late to End-stage Cancer Patients
SINGAPORE, May 18, 2021 /PRNewswire/ -- Farrer Park Hospital
2021-05-18 08:15
2250
AI-for-COVID19: Predictive Diagnostics Platform Available to Global Scientific Community
The "AIforCOVID Imaging Archive" platform enables the sharing of radiographic images from COVID-19 patients and development of leading-edge Artificial Intelligence-based methods for predicting clinical developments of the disease caused by SARS-CoV-2. The platform has been promoted and implement...
2021-05-18 04:44
1679
ISMRM Awards Gold Medals At Annual Meeting And Announces New President
CONCORD, Calif., May 17, 2021 /PRNewswire/ -- The International Society for Magnetic Resonance in Medicine (ISMRM) is holding its Annual Meeting this week and will recognize several achievements with prestigious awards. The Gold Medal award is the organization's highest honor and is awarded to r...
2021-05-17 23:00
2624
EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines
PROVIDENCE, R.I., May 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces the publication"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation" in NPJ Vaccines. This research identifies peptide epitopes associated with T...
2021-05-17 20:54
2431
Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and Commercialize CD73 Inhibitor CB-708 (ATG-037)
SHANGHAI and SOUTH SAN FRANCISCO, Calif., May 17, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in he...
2021-05-17 20:35
4275
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
Dr. Dansey, Seagen's Chief Medical Officer, brings extensive expertise in immuno-oncology and drug development Appointment of industry leader in drug development expands the Board's diverse industry, clinical development, research and commercialization expertise PLYMOUTH MEETING, Pa., May 17, 20...
2021-05-17 20:00
4437
Everest Medicines Announces China NMPA Has Accepted Biologics License Application for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer
SHANGHAI, May 17, 2021 /PRNewswire/ -- Everest Medicines
2021-05-17 16:51
4062
Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London
Industry-leading Centre will provide new collaborative and experiential environment for research, training, and treatments LONDON, May 17, 2021 /PRNewswire/ -- Cynosure announced today the grand opening of its new Cynosure Experience Centre inLondon. Complete with new research and training facil...
2021-05-17 16:00
1888
Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London
Industry-leading Centre will provide new collaborative and experiential environment for research, training, and treatments LONDON, May 17, 2021 /PRNewswire/ -- Cynosure announced today the grand opening of its new Cynosure Experience Centre inLondon. Complete with new research and training facil...
2021-05-17 16:00
2314
Nippon Express (China) Becomes First Japanese Company to Acquire GDP Certification in China
TOKYO, May 17, 2021 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NE China"), a local subsidiary of Nippon Express Co., Ltd., has obtained Good Distribution Practice (GDP) certification, effectiveMonday, March 29, 2021, for its Shanghai Pudong Airport CFS, making it the first Jap...
2021-05-17 15:00
4239
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 271 media titles]
2026-01-01 10:00
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
